Senescent EGR1+ B cells

1 paper1 finding

Humans1

Associations

1

Adverse outcomes

upin humans1

1 study

Senescent EGR1+ B cells predict adverse outcomes in humans.
“EGR1+ B cells emerged as predictors of adverse outcomes in multiple cohorts.”
Humansin ESCC patients receiving NICB
Targeting senescent EGR1⁺ B cells enhances immunotherapy efficacy in esophageal squamous cell carcinoma
Cell reports. Medicine2 Jan 2026

Latest

1 in 12 months

Cell Reports Medicine4 Jan

Targeting senescent EGR1⁺ B cells enhances immunotherapy efficacy in esophageal squamous cell carcinoma

Cohort study in peopleBlood and immune system